Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Caravaggio

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disordersJulia Kim, Eric Plitman, Yusuke Iwata, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2017
The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief ReportJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Psychoneuroendocrinology|April 22, 2017
Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioningFernando Caravaggio, Philip Gerretsen, Wanna Mar, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2018
BASIS: The blood pressure awareness and insight scalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Schizophrenia Bulletin|July 30, 2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical TrialShinichiro Nakajima, Hiroyuki Uchida, Robert R Bies, et al.
Primary Care Diabetes|May 13, 2018
Reprint of OASIS - Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Obesity Medicine|December 4, 2018
OASIS: The Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Psychiatry Research. Neuroimaging|February 8, 2018
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability studyEric Plitman, Sofia Chavez, Shinichiro Nakajima, et al.
Journal of Psychiatric Research|March 15, 2020
Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicityParita Shah, Eric Plitman, Yusuke Iwata, et al.
Schizophrenia (Heidelberg, Germany)|April 29, 2023
Cortical thinning in relation to impaired insight into illness in patients with treatment resistant schizophreniaJulia Kim, Jianmeng Song, Yasaman Kambari, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disordersJulia Kim, Eric Plitman, Yusuke Iwata, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2017
The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief ReportJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Psychoneuroendocrinology|April 22, 2017
Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioningFernando Caravaggio, Philip Gerretsen, Wanna Mar, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2018
BASIS: The blood pressure awareness and insight scalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Schizophrenia Bulletin|July 30, 2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical TrialShinichiro Nakajima, Hiroyuki Uchida, Robert R Bies, et al.
Primary Care Diabetes|May 13, 2018
Reprint of OASIS - Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Obesity Medicine|December 4, 2018
OASIS: The Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Psychiatry Research. Neuroimaging|February 8, 2018
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability studyEric Plitman, Sofia Chavez, Shinichiro Nakajima, et al.
Journal of Psychiatric Research|March 15, 2020
Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicityParita Shah, Eric Plitman, Yusuke Iwata, et al.
Schizophrenia (Heidelberg, Germany)|April 29, 2023
Cortical thinning in relation to impaired insight into illness in patients with treatment resistant schizophreniaJulia Kim, Jianmeng Song, Yasaman Kambari, et al.
Pageof 9